시장보고서

상품코드

1482326

바이오프로세스 시장 규모와 예측, 세계와 지역의 점유율, 동향, 성장 기회 분석 리포트 : 제품별, 규모별, 프로세스별, 용도별, 최종사용자별, 지역별

Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Scale of Operation, Process, Application, End User, and Geography

발행일: 2024년 04월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 300 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오프로세스 시장 규모는 2023년 253억 5,000만 달러에서 2031년에는 755억 5,000만 달러로 급증할 것으로 예측되고 있으며, 2023-2031년 CAGR은 14.0%를 기록할 것으로 예측됩니다. 만성질환의 유병률 증가와 바이오의약품 산업의 성장이 바이오프로세스 시장의 성장을 지원하고 있습니다.

바이오프로세싱은 바이오 의약품 제조를 위해 상업용 생물 반응기에서 살아있는 세포 및 기타 생물학적 시스템/컴포넌트(박테리아, 효소, 단백질, 바이러스, 핵산 등)의 수를 증가시키는 것입니다. 바이오프로세스 분야에서 생산되는 제품에는 일반적으로 현대 의료 발전에 필수적인 고품질 치료제와 백신이 포함되어 있습니다. 현재 바이오프로세스 산업의 상황은 생명공학 기술의 발전과 바이오 의약품에 대한 수요 증가에 힘입어 역동적으로 발전하고 있습니다. 수요 증가는 만성질환의 확산, 맞춤형 의료의 확대, 다양한 분야에서의 바이오프로세싱 용도 증가에 기인합니다. 바이오프로세싱은 치료용 단백질, 백신 및 기타 바이오 제품 생산에 중요한 역할을 하고 있으며, 생명공학 혁명을 실현하는 데 중요한 역할을 하고 있습니다. 시장은 변화하는 헬스케어 수요를 충족시키기 위해 발전하고 있으며, 효율적이고 확장 가능한 바이오 생산 공정의 필요성은 향후 수년간 새로운 바이오프로세스 시장 동향을 가져올 것으로 예상됩니다.

바이오의약품 산업의 성장이 바이오프로세스 시장을 촉진

바이오 제약 산업은 생물학적 제제, 세포 배양 적정 및 바이오시밀러 제조의 새로운 규제 요건, 품질 관리 요건 및 생산 문제를 해결하기 위해 바이오프로세스 개선이 지속적으로 요구되고 있습니다. 최근 수년간 바이오 제약 산업은 전례 없는 속도로 성장하고 있습니다. 바이오제약 기업은 다양한 치료 용도를 위해 의학적 및 상업적 효능이 강화된 새로운 분자를 도입하기 위해 연구개발에 막대한 자금을 투자하고 있습니다. 생물학적 제제 및 바이오시밀러의 연구, 개발 및 제조에 광범위하게 적용되면서 바이오프로세스의 수용성이 점차 확대되고 있습니다. 대형 제약사 및 위탁 연구 기관들은 다양한 적응증을 치료하기 위한 새로운 약물과 치료 형태를 개발하고 있습니다. 또한 만성질환을 치료하기 위한 생물학적 제제 및 바이오시밀러에 대한 수요가 증가하면서 바이오의약품 산업의 성장을 주도하고 있습니다. 바이오의약품 산업은 경제에 가장 큰 기여를 하는 산업 중 하나입니다. 미국은 바이오의약품의 최대 시장이자 바이오의약품 연구개발의 선두주자입니다. 제약연구생산자협회에 따르면 미국 기업은 전 세계 의약품 연구개발의 절반 이상(750억 달러)을 수행하고 있으며, 신약 특허를 가장 많이 보유하고 있습니다. 경제 성장 국가뿐만 아니라 브라질, 중국, 인도 등 신흥 국가의 연구 환경도 빠르게 성장하고 있습니다. 바이오의약품 승인 증가, 바이오시밀러 파이프라인 증가, 연구 활동에 대한 투자 증가, 저렴한 가격의 바이오의약품 개발에 대한 관심 증가 등의 요인이 바이오의약품 산업의 성장을 가속하고 있습니다.

이 외에도 유전자 치료와 세포 치료의 승인 증가는 바이오프로세스 시장의 성장을 가속하고 있습니다. 승인된 유전자 치료제는 글리베라(지단백질 리파제 결핍증 치료제)와 스트림벨리스(ADA-중증 복합 면역결핍증 치료제)가 있습니다. 이러한 요인들은 다양한 치료제의 대규모 생산에 대한 수요를 증가시켜 전 세계 바이오프로세스 시장의 성장을 가속하고 있습니다.

시장 동향

세포치료제 제조 자동화로 전환

세포치료 증가로 인해 전 세계에서 세포치료제 생산은 소량 생산에서 대량 생산으로 전환되고 있습니다. 세포치료제 연구 활동이 활발해짐에 따라 첨단 제조 솔루션에 대한 수요가 증가하고 있습니다. 이러한 배경에서 많은 기업이 학계 연구자 및 대형 생명공학 기업의 니즈를 충족시키는 제품을 제공합니다. 예를 들어 Lonza의 Cocoon과 Miltenyi의 CliniMACS Prodigy 시스템은 CAR-T 공정의 대부분의 연속적인 단위 작업을 하나의 시스템 내에서 자동화할 수 있도록 설계되었습니다. 2019년 5월 GE헬스케어는 완전한 세포치료 워크플로우를 지원하는 크로니클(Chronicle) 웹 용도을 출시하며, 복잡한 세포치료 워크플로우를 지원하는 크로니클 자동화 소프트웨어가 출시되었습니다. 자동화 소프트웨어는 복잡한 세포치료제 공정의 개발 및 제조를 최적화하기 위해 고안된 적정 제조 규범을 준수하는 디지털 솔루션입니다. 기업은 또한 세포 치료의 자동화를 위한 전략적 및 기술적 개발에 참여하고 있습니다. 예를 들어 2020년 7월 써모피셔 사이언티픽과 라이엘 임노파마는 암 환자를 위한 효과적인 세포치료제 개발 및 제조를 위해 제휴를 맺었습니다. 2019년 3월, 론자는 이스라엘의 셰바 메디컬 센터(Sheva Medical Center)와 파트너십을 맺고, 시약, 소모품 및 장비와 함께 통합된 cGMP 준수 플랫폼(시스템 및 소프트웨어)의 개발을 지원하여 T세포의 적합성을 향상시키는 것을 목표로 하고 있습니다. Point-of-Care Cocoon 세포치료제 제조 플랫폼을 이용한 자동화된 폐쇄형 CAR-T 제조를 제공하게 됩니다.

자동화된 절차는 제조 비용을 크게 절감하고 직원의 생산성과 유지율을 높일 수 있습니다. 이러한 요인 외에도 자동화된 공정은 제조 장비 내에서 발생할 수 있는 다양한 오염원을 제한하고 궁극적으로 공정의 일관성을 높입니다. 이처럼 세포치료제 제조업체의 자동화 도입 증가와 세포치료제 분야의 제품 혁신 확대는 세포치료제 바이오프로세스 및 제조를 촉진할 가능성이 높습니다.

세계 바이오프로세싱 시장은 제품, 사업 규모, 공정, 용도, 최종사용자, 지역별로 세분화되어 있습니다.

제품 기반 인사이트

제품 유형에 따라 바이오프로세스 시장은 장비, 소모품 및 액세서리로 구분되며, 장비 부문은 2023년 시장 점유율이 크고 예측 기간 중 14.5%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 장비 부문에는 크로마토그래피 시스템, 여과 장비, 삼투압계, 인큐베이터, 원심분리기, 건조 장비, 바이오리액터 등이 포함됩니다. 크로마토그래피 시스템은 파일럿 규모에서 공정 규모에 이르기까지 고객의 요구사항에 따라 유연한 처리로 지속적인 성능을 제공하는 것을 목표로 합니다. Sartorius AG는 Resolute BioSC 파일럿 멀티 컬럼 크로마토그래피 시스템을 제공합니다. 바이오리액터 설계의 지속적인 발전으로 포유류 및 미생물 세포에서 식물 및 곤충 세포에 이르기까지 다양한 유형의 세포를 수용할 수 있는 정교한 시스템이 개발되고 있습니다. 또한 확장성, 유연성 및 오염 위험 감소를 위해 일회용의 유연한 바이오리액터 기술의 활용이 주목받고 있습니다. 여과 기술의 발전으로 깊이 필터, 멤브레인 필터, 크로마토그래피 수지와 같은 고급 필터 매체가 개발되어 바이오프로세싱 용도의 포집 효율, 확장성 및 순도를 향상시키고 있습니다.

프로세스 기반 인사이트

바이오프로세스 시장은 공정에 따라 다운스트림 바이오프로세스와 업스트림 바이오프로세스로 구분됩니다. 다운스트림 바이오프로세스 분야는 2023년 바이오프로세스 시장 점유율을 독점하고 예측 기간 중 14.4%의 높은 CAGR을 나타낼 것으로 예상됩니다. 업스트림 바이오프로세스는 시장 점유율의 31.2%를 차지합니다. 업스트림 바이오프로세스은 제품의 품질과 생산량의 기초가 되기 때문에 제품의 성공에 매우 중요합니다. 업스트림 바이오프로세스은 미생물, 세포, 박테리아가 다양한 기술과 배지를 통해 배양, 성장 및 개발되는 생산 공정의 초기 단계를 말합니다. 이 단계는 세포 배양과 세포가 배양되는 환경에 대한 첨단 제어가 필요하기 때문에 복잡하고 까다롭습니다. 업스트림 바이오프로세스의 단계는 세포 분리, 배양, 세포 은행, 배양 확대입니다. 또한 인공지능, 머신러닝 등의 기술이 업스트림 바이오프로세스에 필수적인 요소로 자리 잡을 것으로 예상됩니다.

미국 식품의약국, 세계 암 관측소, 세계보건기구, 경제협력개발기구, 국립인간유전체연구소, 국제무역관리국, 제약연구생산자협회 등은 바이오공정 시장 조사 보고서를 작성할 때 참고한 관련 정보원 중 일부입니다.

바이오프로세스 시장 - 주요 시장 역학
시장 촉진요인
- 만성질환의 증가
- 바이오의약품 산업의 성장
시장 억제요인
- 바이오프로세스에 관련된 엄격한 규제 정책과 제한
시장 기회
- 맞춤형 의료에 대한 수요의 증가
향후 동향
- 세포치료 제조 자동화로의 이동
촉진요인과 억제요인의 영향

제6장 바이오프로세스 시장 : 세계 시장 분석

바이오프로세스 시장의 매출, 2023-2031년

제7장 바이오프로세스 시장 분석 : 제품별

기기
소모품과 부속품

제8장 바이오프로세스 시장 분석 : 사업 규모별

상업 오퍼레이션
임상 사업

제9장 바이오프로세스 시장 분석 : 프로세스별

다운스트림 바이오프로세스
업스트림 바이오프로세스

제10장 바이오프로세스 시장 분석 : 용도별

모노클로널 항체
백신
재조합 단백질
세포·유전자 치료
기타

제11장 바이오프로세스 시장 분석 : 최종사용자별

바이오의약품 기업
제조 수탁 기관
기타

제12장 바이오프로세스 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 인도
- 일본
- 한국
- 호주
- APAC 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제13장 업계 상황

바이오프로세스 시장의 성장 전략
무기적 성장 전략
유기적 성장 전략

제14장 기업 개요

Getinge AB
Thermo Fisher Scientific Inc
Sartorius AG
Corning Inc
Bio-Rad Laboratories Inc
Merck KGaA
3M Co
Eppendorf SE
Repligen Corp
Entegris Inc
Agilent Technologies Inc
Cytiva US LLC

제15장 부록

KSA 24.05.31

The bioprocessing market size is projected to surge from US$ 25.35 billion in 2023 to US$ 75.55 billion by 2031; the market is estimated to record a CAGR of 14.0% during 2023-2031. The increasing prevalence of chronic diseases and the growing biopharmaceutical industry propel the bioprocessing market growth.

Bioprocessing increases the number of living cells or other biological systems/components (such as bacteria, enzymes, proteins, viruses, or nucleic acids) in a commercial bioreactor for biopharmaceutical manufacturing. Products produced in the bioprocessing sector typically contain high-quality therapeutics and vaccines critical to modern healthcare advancement. The current bioprocessing industry landscape is characterized by dynamic developments driven by advances in biotechnology and increasing demand for biopharmaceuticals. The increase in demand is attributed to the prevalence of chronic diseases, the growing adoption of personalized medicine, and increasing bioprocessing applications in various sectors. As bioprocessing becomes significantly important in producing therapeutic proteins, vaccines, and other bio-based products, it turns out to be a key enabler of the biotechnological revolution. The market is progressing toward meeting the demands of a changing healthcare landscape, and the need for efficient and scalable bioproduction processes is expected to bring new bioprocessing market trends in the coming years.

Growing Biopharmaceutical Industry Drives the Bioprocessing Market

In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. The US is the largest market for biopharmaceuticals and the leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association, the US firms conduct over half the world's R&D in pharmaceuticals (US$ 75 billion) and hold the highest number of patents in new medicines. Besides growing economies, rapid growth is witnessed in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.

Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market globally.

Market Trend

Shift Toward Automated Cell Therapy Manufacturing

A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. Increasing research activities in cell therapies have led to a rise in the demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the needs of academic researchers and large biotechnology companies. For instance, the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. In addition, the evolution of cell therapy-from an academic and clinical setting to mass production and commercialization-is increasing the demand for automation in manufacturing. In May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice-compliant digital solution designed to optimize complex cell therapy process development and manufacturing. Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated cGMP-compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel's Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform.

Automated procedures can drastically reduce the production cost and enhance staff productivity and retention rates. Other than these factors, automated processes restrict various possible sources of contamination in the manufacturing unit and eventually enhance process consistency, which results in overall good quality products by reducing manual errors. Thus, the increasing adoption of automation among cell therapy manufacturers and the growing product innovations in the field of cell therapy are likely to boost cell therapy bioprocessing or manufacturing.

The "Global Bioprocessing Market" is segmented on the basis of product, scale of operation, process, application, end user, and geography.

Product-Based Insights

Based on product type, the bioprocessing market is segmented into instruments, and consumables and accessories. The instruments segment held a larger market share in 2023 and is anticipated to register a higher CAGR of 14.5% during the forecast period. The instruments segment includes chromatography systems, filtration devices, osmometers, incubators, centrifuges, drying devices, and bioreactors. From pilot to process scale, chromatography systems are intended to provide persistent performance with processing flexibility as per the client's requirement. Sartorius AG offers Resolute BioSC Pilot Multi-Column Chromatography Systems-configurable automated systems with scalability that boost comprehensive support in pre- and post-sales. Ongoing advancements in bioreactor designs have led to the development of sophisticated systems capable of accommodating a range of cell types, from mammalian and microbial cells to plant and insect cells. Moreover, the use of single-use and flexible bioreactor technologies has gained prominence, offering scalability, flexibility, and reduced contamination risks. Advances in filtration technologies have led to the development of advanced filter media, such as depth filters, membrane filters, and chromatographic resins, offering enhanced capture efficiency, scalability, and purity for bioprocessing applications.

Process-Based Insights

Based on process, the bioprocessing market is segmented into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment dominated the bioprocessing market share in 2023 and is anticipated to register a higher CAGR of 14.4% during the forecast period. The upstream bioprocess accounted for 31.2% of the market share. Upstream bioprocessing is critical for the product's success, as it sets the foundation for the quality and quantity of the resultant product. Upstream bioprocessing points toward the initial stages of the production process in which microbes, cells, and bacteria are grown, nurtured, and developed through various technologies and media. These steps are complex and challenging, as high control is required over cell cultures and the environment in which cells are grown. The stages of upstream bioprocessing are cell isolation, cultivation, cell banking, and culture expansion. Furthermore, it is anticipated that technologies such as artificial intelligence and machine learning will be essential in upstream bioprocessing.

US Food and Drug Administration, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, National Human Genome Research Institute, International Trade Administration, and Pharmaceutical Research and Manufacturers Association are some of the relevant sources referred while preparing the bioprocessing market research report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Bioprocessing Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Bioprocessing Market - Key Market Dynamics

5.1 Bioprocessing Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Chronic Diseases
- 5.2.2 Growing Biopharmaceutical Industry
5.3 Market Restraints
- 5.3.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.4 Market Opportunities
- 5.4.1 Proliferating Demand for Personalized Medicine
5.5 Future Trends
- 5.5.1 Shift Toward Automated Cell Therapy Manufacturing
5.6 Impact of Drivers and Restraints:

6. Bioprocessing Market - Global Market Analysis

6.1 Bioprocessing Market Revenue (US$ Million), 2023-2031

7. Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Chromatography Systems
7.3 Consumables and Accessories
- 7.3.1 Overview
- 7.3.2 Consumables and Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Consumables and Accessories

8. Bioprocessing Market Analysis - by Scale Of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell and Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell and Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Bioprocessing Market - Geographical Analysis

12.1 North America: Bioprocessing Market
- 12.1.1 Overview
- 12.1.2 North America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.1.2.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.1.2.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.1.2.1.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.1.2.1.1.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.1.2.1.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.1.2.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.1.2.3 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.1.2.4 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.1.2.5 North America: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.1.3 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.1.3.1 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.1.1 Overview
  - 12.1.3.2 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.2.1 United States: Bioprocessing Market Breakdown, by Product
    - 12.1.3.2.1.1 United States: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.2.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.2.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.2.1.2 United States: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.1.3.2.2 United States: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.1.3.2.3 United States: Bioprocessing Market Breakdown, by Process
    - 12.1.3.2.4 United States: Bioprocessing Market Breakdown, by Application
    - 12.1.3.2.5 United States: Bioprocessing Market Breakdown, by End User
  - 12.1.3.3 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.3.1 Overview
  - 12.1.3.4 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.4.1 Canada: Bioprocessing Market Breakdown, by Product
    - 12.1.3.4.1.1 Canada: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.4.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.4.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.4.1.2 Canada: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.1.3.4.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.3.4.3 Canada: Bioprocessing Market Breakdown, by Process
    - 12.1.3.4.4 Canada: Bioprocessing Market Breakdown, by Application
    - 12.1.3.4.5 Canada: Bioprocessing Market Breakdown, by End User
  - 12.1.3.5 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.5.1 Overview
  - 12.1.3.6 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.6.1 Mexico: Bioprocessing Market Breakdown, by Product
    - 12.1.3.6.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.6.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.6.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.6.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.1.3.6.2 Mexico: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.1.3.6.3 Mexico: Bioprocessing Market Breakdown, by Process
    - 12.1.3.6.4 Mexico: Bioprocessing Market Breakdown, by Application
    - 12.1.3.6.5 Mexico: Bioprocessing Market Breakdown, by End User
12.2 Europe: Bioprocessing Market
- 12.2.1 Overview
- 12.2.2 Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.2.2.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.2.2.1.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.2.2.1.1.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.2.2.1.1.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.2.2.1.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.2.2.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.2.2.3 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.2.2.4 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.2.2.5 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.2.3 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.2.3.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.1.1 Overview
  - 12.2.3.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.2.1 Germany: Bioprocessing Market Breakdown, by Product
    - 12.2.3.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.2.2 Germany: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.2.3 Germany: Bioprocessing Market Breakdown, by Process
    - 12.2.3.2.4 Germany: Bioprocessing Market Breakdown, by Application
    - 12.2.3.2.5 Germany: Bioprocessing Market Breakdown, by End User
  - 12.2.3.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.3.1 Overview
  - 12.2.3.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
    - 12.2.3.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
    - 12.2.3.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
    - 12.2.3.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
  - 12.2.3.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.5.1 Overview
  - 12.2.3.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.6.1 France: Bioprocessing Market Breakdown, by Product
    - 12.2.3.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.6.1.2 France: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.6.2 France: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.6.3 France: Bioprocessing Market Breakdown, by Process
    - 12.2.3.6.4 France: Bioprocessing Market Breakdown, by Application
    - 12.2.3.6.5 France: Bioprocessing Market Breakdown, by End User
  - 12.2.3.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.7.1 Overview
  - 12.2.3.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.8.1 Italy: Bioprocessing Market Breakdown, by Product
    - 12.2.3.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.8.3 Italy: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.8.4 Italy: Bioprocessing Market Breakdown, by Process
    - 12.2.3.8.5 Italy: Bioprocessing Market Breakdown, by Application
    - 12.2.3.8.6 Italy: Bioprocessing Market Breakdown, by End User
  - 12.2.3.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.9.1 Overview
  - 12.2.3.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.10.1 Spain: Bioprocessing Market Breakdown, by Product
    - 12.2.3.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.2.3.10.2 Spain: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.10.3 Spain: Bioprocessing Market Breakdown, by Process
    - 12.2.3.10.4 Spain: Bioprocessing Market Breakdown, by Application
    - 12.2.3.10.5 Spain: Bioprocessing Market Breakdown, by End User
  - 12.2.3.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.11.1 Overview
  - 12.2.3.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
    - 12.2.3.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.2.3.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
    - 12.2.3.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
    - 12.2.3.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
12.3 Asia Pacific: Bioprocessing Market
- 12.3.1 Overview
- 12.3.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.3.2.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.3.2.1.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.3.2.1.1.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.3.2.1.1.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.3.2.1.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables and Accessories
  - 12.3.2.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Scale of Operation
  - 12.3.2.3 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.3.2.4 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.3.2.5 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.3.3 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.3.3.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.1.1 Overview
  - 12.3.3.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.2.1 China: Bioprocessing Market Breakdown, by Product
    - 12.3.3.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.2.2 China: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.2.3 China: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.2.4 China: Bioprocessing Market Breakdown, by Process
    - 12.3.3.2.5 China: Bioprocessing Market Breakdown, by Application
    - 12.3.3.2.6 China: Bioprocessing Market Breakdown, by End User
  - 12.3.3.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.3.1 Overview
  - 12.3.3.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.4.1 India: Bioprocessing Market Breakdown, by Product
    - 12.3.3.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.4.1.2 India: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.4.2 India: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.4.3 India: Bioprocessing Market Breakdown, by Process
    - 12.3.3.4.4 India: Bioprocessing Market Breakdown, by Application
    - 12.3.3.4.5 India: Bioprocessing Market Breakdown, by End User
  - 12.3.3.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.5.1 Overview
  - 12.3.3.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.6.1 Japan: Bioprocessing Market Breakdown, by Product
    - 12.3.3.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.3.3.6.2 Japan: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.6.3 Japan: Bioprocessing Market Breakdown, by Process
    - 12.3.3.6.4 Japan: Bioprocessing Market Breakdown, by Application
    - 12.3.3.6.5 Japan: Bioprocessing Market Breakdown, by End User
  - 12.3.3.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.7.1 Overview
  - 12.3.3.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.8.1 South Korea: Bioprocessing Market Breakdown, by Product
    - 12.3.3.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.8.2 South Korea: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.8.3 South Korea: Bioprocessing Market Breakdown, by Process
    - 12.3.3.8.4 South Korea: Bioprocessing Market Breakdown, by Application
    - 12.3.3.8.5 South Korea: Bioprocessing Market Breakdown, by End User
  - 12.3.3.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.9.1 Overview
  - 12.3.3.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.10.1 Australia: Bioprocessing Market Breakdown, by Product
    - 12.3.3.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.3.3.10.2 Australia: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.10.3 Australia: Bioprocessing Market Breakdown, by Process
    - 12.3.3.10.4 Australia: Bioprocessing Market Breakdown, by Application
    - 12.3.3.10.5 Australia: Bioprocessing Market Breakdown, by End User
  - 12.3.3.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.11.1 Overview
  - 12.3.3.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
    - 12.3.3.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
    - 12.3.3.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
    - 12.3.3.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
12.4 Middle East & Africa: Bioprocessing Market
- 12.4.1 Overview
- 12.4.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.4.2.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.4.2.1.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.4.2.1.1.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.4.2.1.1.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.4.2.1.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.4.2.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.4.2.3 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.4.2.4 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.4.2.5 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.4.3 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.1.1 Overview
  - 12.4.3.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
    - 12.4.3.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
    - 12.4.3.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
    - 12.4.3.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
  - 12.4.3.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.3.1 Overview
  - 12.4.3.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.4.1 South Africa: Bioprocessing Market Breakdown, by Product
    - 12.4.3.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.4.2 South Africa: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.4.3 South Africa: Bioprocessing Market Breakdown, by Process
    - 12.4.3.4.4 South Africa: Bioprocessing Market Breakdown, by Application
    - 12.4.3.4.5 South Africa: Bioprocessing Market Breakdown, by End User
  - 12.4.3.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.5.1 Overview
  - 12.4.3.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
    - 12.4.3.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
    - 12.4.3.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
    - 12.4.3.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
  - 12.4.3.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.7.1 Overview
  - 12.4.3.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
    - 12.4.3.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
    - 12.4.3.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
    - 12.4.3.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12.5 South & Central America: Bioprocessing Market
- 12.5.1 Overview
- 12.5.2 South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.5.2.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.5.2.1.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.5.2.1.1.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.5.2.1.1.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.5.2.1.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.5.2.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.5.2.3 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.5.2.4 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.5.2.5 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.5.3 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.1 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.1.1 Overview
  - 12.5.3.2 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.2.1 Brazil: Bioprocessing Market Breakdown, by Product
    - 12.5.3.2.1.1 Brazil: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.2.1.1.1 Brazil: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.2.1.1.2 Brazil: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.2.1.2 Brazil: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.2.2 Brazil: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.2.3 Brazil: Bioprocessing Market Breakdown, by Process
    - 12.5.3.2.4 Brazil: Bioprocessing Market Breakdown, by Application
    - 12.5.3.2.5 Brazil: Bioprocessing Market Breakdown, by End User
  - 12.5.3.3 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.3.1 Overview
  - 12.5.3.4 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.4.1 Argentina: Bioprocessing Market Breakdown, by Product
    - 12.5.3.4.1.1 Argentina: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.4.1.1.1 Argentina: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.4.1.1.2 Argentina: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.4.1.2 Argentina: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.4.2 Argentina: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.4.3 Argentina: Bioprocessing Market Breakdown, by Process
    - 12.5.3.4.4 Argentina: Bioprocessing Market Breakdown, by Application
    - 12.5.3.4.5 Argentina: Bioprocessing Market Breakdown, by End User
  - 12.5.3.5 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.5.1 Overview
  - 12.5.3.6 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.6.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Product
    - 12.5.3.6.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.6.1.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.6.1.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.6.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.6.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.6.3 Rest of South & Central America: Bioprocessing Market Breakdown, by Process
    - 12.5.3.6.4 Rest of South & Central America: Bioprocessing Market Breakdown, by Application
    - 12.5.3.6.5 Rest of South & Central America: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms